I am happy to share that our project on the study of m6A in AML progression got selected to receive one year of funding from the Edward P. Evans Center for Myelodysplastic Syndromes.
We are delighted to be part of the Edward P. Evans Center for Myelodysplastic Syndromes at Columbia University Medical Center. This award represents a significant opportunity for us to expand our knowledge of m6A regulation in MDS and AML and contribute to the advancement of this field.
To read more about our project and to know more about the other winners, please visit the website below:
https://www.cancer.columbia.edu/news/edward-p-evans-center-myelodysplastic-syndromes-announces-2023-pilot-awards-and-fellowships
